Role of C5 Activation Products in Sepsis
Complement activation products are known to be generated in the setting of both experimental and human sepsis. C5 activation products (C5a anaphylatoxin and the membrane attack complex [MAC] C5b-9) are generated during sepsis following infusion of endotoxin, or after cecal ligation and puncture (CLP...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
TheScientificWorldJOURNAL
2010
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100663/ |